| 期 |
标题 |
文件 |
| 卷 41, 编号 3 (2024) |
Brain insulin resistance in neurological disorders of various genesis: current state and treatment approaches |
(Rus)
|
|
Zorina I., Shpakov A.
|
| 卷 41, 编号 2 (2024) |
N-Cadherin — A Potential Target for Psychopharmacology |
(Rus)
|
|
Firstova Y., Kovalev G.
|
| 卷 41, 编号 1 (2024) |
Ciliary neurotrophic factor as a potential biomarker of cerebral pathologies |
(Rus)
|
|
Gudkova A.
|
| 卷 41, 编号 1 (2024) |
Promising markers of neuroinflammation in schizophrenia |
(Rus)
|
|
Sakharov A., Golygina S.
|
| 卷 41, 编号 1 (2024) |
Stress influences and cognitive activity: search for targets and general mechanisms using Drosophila mutants |
(Rus)
|
|
Karovetskaya D., Medvedeva A., Tokmacheva E., Vasilyeva S., Rebrova A., Nikitina E., Shchegolev B., Savvateeva-Popova E.
|
| 卷 40, 编号 4 (2023) |
Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C |
(Rus)
|
|
Korolenko T., Pupyshev A., Belichenko V., Tikhonova M., Amstislavskaya T.
|
| 卷 40, 编号 4 (2023) |
Multiple Mechanisms of the Therapeutic Effect of Trehalose in Inhibition of Experimental Neurodegeneration |
(Rus)
|
|
Pupyshev A., Korolenko T., Tikhonova M.
|
| 卷 40, 编号 4 (2023) |
Role of VEGF in Angiogenesis and Motor Recovery after Ischemic Stroke |
(Rus)
|
|
Kucherova K., Koroleva E., Alifirova V.
|
| 卷 40, 编号 4 (2023) |
Structural Determinants of Small Extracellular Vesicles (Exosomes) and Their Role in Biological Functions |
(Rus)
|
|
Tourchinets A., Yakovlev A.
|
| 卷 40, 编号 4 (2023) |
State-of-the-Art: the Use of Extracellular Vesicles and Preparations Based on Them for Neuroprotection and Stimulation of Brain Tissue Regeneration after Injury |
(Rus)
|
|
Basalova N., Dzhauari S., Yurshev Y., Primak A., Efimenko A., Tkachuk V., Karagyaur M.
|
| 卷 40, 编号 4 (2023) |
Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetic-Targeted Therapeutic Approaches |
(Rus)
|
|
Boksha I., Prokhorova T., Savushkina O., Tereshkina E., Vorobyeva E., Burbaeva G.
|
| 卷 40, 编号 4 (2023) |
T-Cell Aspects of Some Neurological Diseases |
(Rus)
|
|
Kvichansky A., Bolshakov A.
|
| 卷 40, 编号 3 (2023) |
Metabolic Plasticity of a Developing and Aging Brain |
(Rus)
|
|
Salmina A.
|
| 卷 40, 编号 3 (2023) |
Markers of Neurodegeneration in Parkinson’s Disease |
(Rus)
|
|
Nikitina M., Alifirova V., Borodina S., Koroleva E.
|
| 卷 40, 编号 2 (2023) |
The Origins and Background of the Creation of the Nootropics Concept |
(Rus)
|
|
Shabanov P.
|
| 卷 40, 编号 2 (2023) |
Creation and Study of the Mechanism of Action of Compounds of a New Class of Positive Modulators of AMPA Receptors – Derivatives of 3,7-Diazabicyclo[3.3.1]nonanes |
(Rus)
|
|
Grigoriev V., Lavrov M., Palyulin V., Garibova T., Anokhin K., Bachurin S.
|
| 卷 40, 编号 2 (2023) |
Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects |
(Rus)
|
|
Voronina T.
|
| 卷 40, 编号 2 (2023) |
Irisin at the Crossroad of Autophagy and BNDF Signaling for Neuroplasticity Regulation |
(Rus)
|
|
Andyarzhanova E., Voronina T.
|
| 卷 40, 编号 2 (2023) |
Neurodevelopmental Disorders in Children: Neuroplasticity and Possibilities of Nootropic Pharmacotherapy |
(Rus)
|
|
Zavadenko N.
|
| 卷 40, 编号 1 (2023) |
Biochemical Platelet Markers of Cognitive Impairment in Alzheimer’s Disease |
(Rus)
|
|
Kodintcev A., Izmozherova N., Popov A., Volkova L., Antropova I., Ryabinina A.
|
| 卷 40, 编号 1 (2023) |
Interleukin-6 Role in Schizophrenia Pathological Mechanisms |
(Rus)
|
|
Rukavishnikov G., Zhilyaeva T., Dubinina E., Mazo G.
|
| 卷 40, 编号 1 (2023) |
Neurospecific Proteins as Transdiagnostic Markers of Affective Disorders |
(Rus)
|
|
Levchuk L., Bokhan N., Ivanova S.
|
| 卷 40, 编号 1 (2023) |
Outlooks of Using Small Extracellular Vesicles as a Transport Vehicle through the Blood–Brain Barrier |
(Rus)
|
|
Khaspekov L., Yakovlev A.
|
| 1 - 23 的 23 信息 |
|
